Liver disease is a silent epidemic. Nearly 30% of the global population are affected by MASLD, yet only 5% of them are aware of their condition1. The symptoms are silent, but the damage is not. When detected early, liver disease can be treated and even reversed.
This is where ultrasound changes everything. Unlike MRI or biopsy, ultrasound is non-invasive, accessible and scalable. It allows clinicians to perform one-minute abdominal scans during routine exams, detecting liver disease proactively, before it progresses.
The need for non-invasive liver disease evaluation
Early assessment and characterization of hepatic steatosis while still in the initial reversible stage is key to overall disease management and improved patient outcomes. Explore each step of the journey, from undiagnosed liver disease to invasive assessment.
Enabling proactive liver health management for everyone, everywhere
Siemens Healthineers advances liver care with innovative ultrasound technologies designed to address real clinical challenges. From precise fat quantification to deep abdominal imaging, these solutions enable fast, reproducible, and efficient assessments, empowering confident liver disease evaluation.
Ultrasound Derived Fat Fraction (UDFF)
UDFF can quantify the amount of fat within a patient’s liver quickly and painlessly in just seconds* during a routine abdominal ultrasound. UDFF on ACUSON Sequoia shows a good agreement with MRI Proton Density Fat Fraction (MRI-PDFF) to aid clinicians in determining hepatic steatosis.2
Auto Point Shear Wave Elastography (Auto pSWE)
Auto Point Shear Wave Elastography (Auto pSWE) technology offers rapid, reproducible liver stiffness measurements. Historically, point shear wave elastography (pSWE) required individual acquisitions. With Auto pSWE, the process is automated, ensuring up to 15 valid assessments in under 1 minute and reducing exam time by up to 50%**.
Deep Abdominal Transducer (DAX)
The ACUSON Sequoia's Deep Abdominal Transducer (DAX) provides increased diagnostic confidence in patient populations limited by conventional ultrasound technology. DAX has the capability to image at diagnostic depths of up to 55 cm, while also reducing the need for excessive transducer pressure.
Contrast-enhanced ultrasound (CEUS)
Contrast-enhanced ultrasound (CEUS) improves characterization of focal liver lesions by visualizing real-time vascular patterns and washout behavior, helping differentiate benign from malignant lesions quickly, safely, and without exposure to ionizing radiation.
